Degarelix

Trade Name: 
Firmagon
Manufacturer/Distributor: 
Ferring
1-800-263-4057
Classification: 
Antineoplastic agent
ATC Class: 
L02BX02 - Degarelix
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2009/11/16
Date Marketed in Canada (yyyy/mm/dd): 
2009/11
Presentation: 
Injection: 80 mg/vial, DIN 02337029
Injection: 120 mg/vial, DIN 02337037
Comments: 
Gonadotropin-releasing receptor antagonist for testosterone suppression in patients with advanced hormone-dependent prostate cancer in whom androgen deprivation is warranted.